Loading...
Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world
Both apixaban and rivaroxaban have been approved for use in acute venous thromboembolism (VTE). Although indirect comparison through network meta-analyses of randomized trials have been performed to compare the efficacy and safety of these agents, further comparison between these agents was lacking...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693001/ https://ncbi.nlm.nih.gov/pubmed/31405948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000572 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|